What is Major Depressive Disorder?
Major Depressive Disorder (MDD), also referred as depression, is a serious medical illness that disrupts a person’s mood, behavior, thought processes, apart from degrading the physical health.
How Major Depressive Disorder affected population?
Major Depressive Disorder Epidemiology
· The most prevalent cases of Major Depressive Disorder (MDD) were recorded in the United States.
· Among the European 5 countries, France had highest prevalent population of Major Depressive Disorder (MDD), followed by Germany and Spain. On the other hand, the United Kingdom had the lowest prevalent population of Major Depressive Disorder (MDD)
· The third most prevalent cases of Major Depressive Disorder (MDD) in 7MM were recorded in Japan.
To know more, request sample pages of Major Depressive Disorder Market @ https://www.delveinsight.com/report-store/major-depressive-disorder-market
Major Depressive Disorder Market Outlook
The various major American and European guidelines for the treatment of depression provide similar basic principles of treatment, which include individualizing the treatment plan, preparing the patient for potential long-term treatment, providing measurement-based care, and treating to remission.
The new evidence-based guideline summarizes recommendations on the use of antidepressants and other drug therapies; psychotherapy, including cognitive behavior therapy; and Electroconvulsive Therapy (ECT).
Apart from therapies, companies are also focussed on the development of technologies that could further assist in the better management of the disease. BrainsWay’s Deep TMS received FDA clearance in 2018 to treat MDD. Deep TMS works by utilizing a magnetic field that manages to directly reach wider and deeper brain regions, regulating the neural activity of brain structures related to depression – specifically the dorsolateral prefrontal cortex (DLPFC).
What are the Major Depressive Disorder Market Drivers?
Introduction of new pathway, increasing awareness on depression, and increasing spending on branded drugs are the present Major Depressive Disorder market drivers.
What are the Major Depressive Disorder Market Barriers?
Challenges in diagnoses, economic burden, and generic products are the Major Depressive Disorder market barriers.
Which are the leading companies in Major Depressive Disorder market?
The emerging treatment options in Major Depressive Disorder Market Landscapeaim to improve the responses which are inadequate with respect to standard antidepressant therapies. Companies such as Axsome Therapeutics, SAGE Therapeutics, J&J/ Minerva Neurosciences, Intra-Cellular Therapies, and others are developing the therapies to transform the Major Depressive Disorder treatment scenario.
Request sample pages for more information on Major Depressive Disorder Market @ https://www.delveinsight.com/sample-request/major-depressive-disorder-market